HEADER IMMUNE SYSTEM/INHIBITOR 10-JAN-19 6NM8 TITLE IGV-V76T BMS COMPOUND 105 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROGRAMMED CELL DEATH 1 LIGAND 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROGRAMMED DEATH LIGAND 1,B7 HOMOLOG 1,B7-H1; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FRAGMENT-BASED SCREENING, STRUCTURE-BASED DESIGN, PD-L1 INHIBITOR, KEYWDS 2 CANCER DRUG DISCOVERY, IMMUNOTHERAPY, IMMUNE SYSTEM, IMMUNE SYSTEM- KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.PERRY,B.ZHAO,S.FESIK REVDAT 4 11-OCT-23 6NM8 1 REMARK REVDAT 3 27-NOV-19 6NM8 1 REMARK REVDAT 2 27-FEB-19 6NM8 1 JRNL REVDAT 1 20-FEB-19 6NM8 0 JRNL AUTH E.PERRY,J.J.MILLS,B.ZHAO,F.WANG,Q.SUN,P.P.CHRISTOV,J.C.TARR, JRNL AUTH 2 T.A.RIETZ,E.T.OLEJNICZAK,T.LEE,S.FESIK JRNL TITL FRAGMENT-BASED SCREENING OF PROGRAMMED DEATH LIGAND 1 JRNL TITL 2 (PD-L1). JRNL REF BIOORG. MED. CHEM. LETT. V. 29 786 2019 JRNL REFN ESSN 1464-3405 JRNL PMID 30728114 JRNL DOI 10.1016/J.BMCL.2019.01.028 REMARK 2 REMARK 2 RESOLUTION. 2.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.26 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 6786 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.304 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 345 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 20.2638 - 3.5145 1.00 3343 188 0.1763 0.2734 REMARK 3 2 3.5145 - 2.7919 0.98 3098 157 0.2365 0.3762 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.250 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 18 THROUGH 30 OR REMARK 3 RESID 32 THROUGH 35 OR RESID 37 THROUGH REMARK 3 142)) REMARK 3 SELECTION : (CHAIN B AND (RESID 18 THROUGH 30 OR REMARK 3 RESID 32 THROUGH 35 OR RESID 37 THROUGH REMARK 3 141 OR RESID 143)) REMARK 3 ATOM PAIRS NUMBER : 724 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6NM8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1000238893. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-AUG-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0003 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6839 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.792 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 11.70 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 12.60 REMARK 200 R MERGE FOR SHELL (I) : 0.59200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6NP9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 29% PEG 4000, 0.28 M NACL, 0.01 M REMARK 280 TRIS, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.30200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.63600 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.30200 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 70.63600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 17 REMARK 465 HIS A 143 REMARK 465 HIS A 144 REMARK 465 HIS A 145 REMARK 465 MET B 17 REMARK 465 HIS B 144 REMARK 465 HIS B 145 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 45 CG CD OE1 OE2 REMARK 470 GLN A 47 CG CD OE1 NE2 REMARK 470 HIS A 142 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 45 CG CD OE1 OE2 REMARK 470 GLN B 47 CG CD OE1 NE2 REMARK 470 HIS B 143 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 40 CA - CB - SG ANGL. DEV. = 7.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 32 134.76 -35.87 REMARK 500 LYS A 46 -153.93 -113.92 REMARK 500 GLU A 60 -112.94 50.95 REMARK 500 SER A 79 -60.09 -27.74 REMARK 500 SER A 80 2.11 -67.90 REMARK 500 LYS B 46 -138.32 -124.19 REMARK 500 SER B 79 -57.12 -26.74 REMARK 500 GLN B 83 14.73 52.71 REMARK 500 LEU B 88 92.94 -69.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KSD A 201 DBREF 6NM8 A 19 134 UNP Q9NZQ7 PD1L1_HUMAN 19 134 DBREF 6NM8 B 19 134 UNP Q9NZQ7 PD1L1_HUMAN 19 134 SEQADV 6NM8 MET A 17 UNP Q9NZQ7 INITIATING METHIONINE SEQADV 6NM8 ALA A 18 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 THR A 76 UNP Q9NZQ7 VAL 76 ENGINEERED MUTATION SEQADV 6NM8 ALA A 135 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 ALA A 136 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 ALA A 137 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 LEU A 138 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 GLU A 139 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS A 140 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS A 141 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS A 142 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS A 143 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS A 144 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS A 145 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 MET B 17 UNP Q9NZQ7 INITIATING METHIONINE SEQADV 6NM8 ALA B 18 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 THR B 76 UNP Q9NZQ7 VAL 76 ENGINEERED MUTATION SEQADV 6NM8 ALA B 135 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 ALA B 136 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 ALA B 137 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 LEU B 138 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 GLU B 139 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS B 140 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS B 141 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS B 142 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS B 143 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS B 144 UNP Q9NZQ7 EXPRESSION TAG SEQADV 6NM8 HIS B 145 UNP Q9NZQ7 EXPRESSION TAG SEQRES 1 A 129 MET ALA PHE THR VAL THR VAL PRO LYS ASP LEU TYR VAL SEQRES 2 A 129 VAL GLU TYR GLY SER ASN MET THR ILE GLU CYS LYS PHE SEQRES 3 A 129 PRO VAL GLU LYS GLN LEU ASP LEU ALA ALA LEU ILE VAL SEQRES 4 A 129 TYR TRP GLU MET GLU ASP LYS ASN ILE ILE GLN PHE VAL SEQRES 5 A 129 HIS GLY GLU GLU ASP LEU LYS THR GLN HIS SER SER TYR SEQRES 6 A 129 ARG GLN ARG ALA ARG LEU LEU LYS ASP GLN LEU SER LEU SEQRES 7 A 129 GLY ASN ALA ALA LEU GLN ILE THR ASP VAL LYS LEU GLN SEQRES 8 A 129 ASP ALA GLY VAL TYR ARG CYS MET ILE SER TYR GLY GLY SEQRES 9 A 129 ALA ASP TYR LYS ARG ILE THR VAL LYS VAL ASN ALA PRO SEQRES 10 A 129 TYR ALA ALA ALA LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 129 MET ALA PHE THR VAL THR VAL PRO LYS ASP LEU TYR VAL SEQRES 2 B 129 VAL GLU TYR GLY SER ASN MET THR ILE GLU CYS LYS PHE SEQRES 3 B 129 PRO VAL GLU LYS GLN LEU ASP LEU ALA ALA LEU ILE VAL SEQRES 4 B 129 TYR TRP GLU MET GLU ASP LYS ASN ILE ILE GLN PHE VAL SEQRES 5 B 129 HIS GLY GLU GLU ASP LEU LYS THR GLN HIS SER SER TYR SEQRES 6 B 129 ARG GLN ARG ALA ARG LEU LEU LYS ASP GLN LEU SER LEU SEQRES 7 B 129 GLY ASN ALA ALA LEU GLN ILE THR ASP VAL LYS LEU GLN SEQRES 8 B 129 ASP ALA GLY VAL TYR ARG CYS MET ILE SER TYR GLY GLY SEQRES 9 B 129 ALA ASP TYR LYS ARG ILE THR VAL LYS VAL ASN ALA PRO SEQRES 10 B 129 TYR ALA ALA ALA LEU GLU HIS HIS HIS HIS HIS HIS HET KSD A 201 32 HETNAM KSD N-({2,6-DIMETHOXY-4-[(2-METHYL[1,1'-BIPHENYL]-3-YL) HETNAM 2 KSD METHOXY]PHENYL}METHYL)-D-ALANINE FORMUL 3 KSD C26 H29 N O5 HELIX 1 AA1 ASP A 49 ALA A 51 5 3 HELIX 2 AA2 HIS A 78 ARG A 82 5 5 HELIX 3 AA3 LEU A 88 SER A 93 1 6 HELIX 4 AA4 LYS A 105 ALA A 109 5 5 HELIX 5 AA5 PRO A 133 HIS A 142 1 10 HELIX 6 AA6 ASP B 49 ALA B 51 5 3 HELIX 7 AA7 HIS B 78 ARG B 82 5 5 HELIX 8 AA8 LYS B 89 SER B 93 5 5 HELIX 9 AA9 LYS B 105 ALA B 109 5 5 HELIX 10 AB1 PRO B 133 HIS B 141 1 9 SHEET 1 AA1 6 LEU A 27 GLU A 31 0 SHEET 2 AA1 6 ALA A 121 ASN A 131 1 O THR A 127 N TYR A 28 SHEET 3 AA1 6 GLY A 110 TYR A 118 -1 N TYR A 112 O ILE A 126 SHEET 4 AA1 6 LEU A 53 MET A 59 -1 N TYR A 56 O MET A 115 SHEET 5 AA1 6 LYS A 62 VAL A 68 -1 O ILE A 64 N TRP A 57 SHEET 6 AA1 6 GLU A 71 ASP A 73 -1 O ASP A 73 N GLN A 66 SHEET 1 AA2 3 MET A 36 ILE A 38 0 SHEET 2 AA2 3 LEU A 99 ILE A 101 -1 O ILE A 101 N MET A 36 SHEET 3 AA2 3 ALA A 85 LEU A 87 -1 N ARG A 86 O GLN A 100 SHEET 1 AA3 6 LEU B 27 GLU B 31 0 SHEET 2 AA3 6 ALA B 121 ASN B 131 1 O LYS B 129 N TYR B 28 SHEET 3 AA3 6 GLY B 110 TYR B 118 -1 N TYR B 112 O ILE B 126 SHEET 4 AA3 6 LEU B 53 MET B 59 -1 N TYR B 56 O MET B 115 SHEET 5 AA3 6 ASN B 63 VAL B 68 -1 O ILE B 64 N TRP B 57 SHEET 6 AA3 6 GLU B 71 ASP B 73 -1 O ASP B 73 N GLN B 66 SHEET 1 AA4 3 MET B 36 ILE B 38 0 SHEET 2 AA4 3 LEU B 99 ILE B 101 -1 O LEU B 99 N ILE B 38 SHEET 3 AA4 3 ALA B 85 LEU B 87 -1 N ARG B 86 O GLN B 100 SSBOND 1 CYS A 40 CYS A 114 1555 1555 2.03 SSBOND 2 CYS B 40 CYS B 114 1555 1555 2.00 SITE 1 AC1 12 TYR A 56 GLN A 66 VAL A 68 SER A 117 SITE 2 AC1 12 ALA B 18 PHE B 19 THR B 20 TYR B 56 SITE 3 AC1 12 LYS B 75 ALA B 121 ASP B 122 TYR B 123 CRYST1 33.455 54.604 141.272 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029891 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018314 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007079 0.00000